Real Estate·Health Care REITs·$39.8B
Ventas Inc REIT is a real estate investment trust focused on healthcare properties, including senior housing and medical office buildings. With a market cap of $39 billion, it plays a crucial role in the healthcare real estate sector, which is increasingly important as the population ages and healthcare needs grow.
EPS
Earnings per share is a key indicator of profitability and investor returns, and this quarter's consensus is particularly low, suggesting cautious expectations.
Revenue
Revenue figures provide insight into the company's overall performance and ability to generate cash flow, which is vital for a REIT.
Wall Street expectations, options signals, track record, and call prep available with Pro.
EPS Beat Streak
5Q
EPS Beat Rate
63%
Avg EPS Surprise
+0.96%
Avg Stock Reaction
+0.62%
In Q4-2025, Ventas reported an EPS of $0.91, slightly beating expectations. The stock reacted positively, gaining 2.71% the following day.
Management Promises & Guidance
Analysts expect Ventas to report modest earnings this quarter, with a consensus EPS of $0.10. The market is watching closely for any signs of growth or stability in revenue.
Bull Case
If Ventas can exceed EPS expectations and show strong revenue growth, it could signal a recovery in the healthcare real estate sector, boosting investor confidence.
Bear Case
Conversely, if the company misses EPS estimates or shows stagnant revenue, it could raise concerns about its ability to manage its portfolio effectively in a challenging market.
EPS
$0.10Earnings per share is a key indicator of profitability and investor returns, and this quarter's consensus is particularly low, suggesting cautious expectations.
Revenue
$1.6BRevenue figures provide insight into the company's overall performance and ability to generate cash flow, which is vital for a REIT.
The print will turn on these two things.
Q1
Will Ventas achieve an EPS of $0.10 or better?
This is critical as it will determine whether the company can maintain investor confidence and support its stock price.
Q2
What are the revenue trends for the healthcare properties?
Understanding revenue trends will provide insight into the company's operational health and its ability to navigate market challenges.
Why consensus could be wrong
The consensus is overly cautious about Ventas' growth potential, underestimating the recovery in healthcare demand and the company's strategic positioning.
Supporting Evidence
The recent EPS beat rate of 63% suggests Ventas has a history of exceeding expectations.
Options pricing indicates a higher expected move than historical averages, suggesting traders anticipate significant news.
Past performance shows that the stock often reacts positively to earnings beats, indicating potential for upside.
Key Risk
If revenue shows unexpected growth, it could challenge the current cautious outlook and shift investor sentiment.
Pre-commit to what would confirm each case.
This quarter's performance is pivotal as it reflects the company's ability to adapt to market conditions and investor expectations.
Bull Confirmed If
An EPS of $0.11 or higher would confirm strong operational performance and investor confidence.
Bear Confirmed If
An EPS below $0.09 would raise significant concerns about the company's growth prospects.
Implied Move
±2.20%
Historical Avg
±1.1%
The options market is pricing in a move of about 2.2%, indicating that traders expect some volatility around the earnings announcement.
Options are pricing ±2.2% while VTR has averaged ±1.1% over the last 8 prints — setup is pricing rich.
Likely market behavior by outcome — not investment advice.
Beat & Raise
If Ventas beats expectations, history suggests the stock could rise by around 0.76% on the first day, confirming a positive outlook.
In-Line / Cautious
If results are in line with expectations, the stock may see muted movement as investors await further guidance from management.
Miss
A miss could lead to a decline of about 0.40% based on historical patterns, indicating investor disappointment.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
NORFOLK SOUTHN CORP
Apr 24, 2026